Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial

Elvira Isganaitis, Dan Raghinaru, Louise Ambler-Osborn, +87

Diabetes Technology & Therapeutics

Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial

Yogish C. Kudva, Lori M. Laffel, Sue A. Brown, +80

Diabetes Technology & Therapeutics

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial

Sue A. Brown, Roy W. Beck, Dan Raghinaru, +109

Diabetes Care

Contrast-enhanced ultrasound with sub-micron sized contrast agents detects insulitis in mouse models of type1 diabetes

David G. Ramirez, Eric Abenojar, Christopher Hernandez, +6

Nature Communications

Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models

Joshua R. St. Clair, David G. Ramirez, Samantha Passman, +1

Nature Communications

Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial

Grenye O’Malley, Laurel H. Messer, Carol J. Levy, +73

Diabetes Technology & Therapeutics

Insulin Delivery and Glucose Variability Throughout the Menstrual Cycle on Closed Loop Control for Women with Type 1 Diabetes

Carol J. Levy, Grenye O’Malley, Dan Raghinaru, +82

Diabetes Technology & Therapeutics

Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4

Jordan E. Pinsker, Eyal Dassau, Sunil Deshpande, +42

Diabetes Technology & Therapeutics